Emend Merck - Treatment for Chemotherapy-Induced Nausea and Vomiting (CINV)
Emend is a P/neurokinin 1 (NK1) receptor antagonist used in combination with other antiemetic agents to prevent and control acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.Posted: March 2003
